Morgan Stanley lifts rating on Walgreen Company!
Analyst Mark Wiltamuth raised his rating on the drug store chain to "overweight," or "buy," from "equal-weight," and set a $45 price target on the shares, implying he expects the stock to rise about 19 percent in the next year.
Such a gain would reverse the stock's decline since Oct. 1, when Walgreen posted results sharply short of Wall Street expectations.
www.chicagotribune.com/business/071022walgreen,0,599991.story%3ftrack=rss